- Relmada Therapeutics to Report Fourth Quarter and Full-Year 2022 Financial Results and Host Conference Call and Webcast on March 23, 2023
- Relmada Therapeutics Appoints Fabiana Fedeli from M&G Investments to its Board of Directors
- Relmada Therapeutics Appoints CNS Therapeutic Expert Cedric O'Gorman MD as Chief Medical Officer
Relmada Therapeutics Inc (4E2:DEU) closed at 2.32, 14.85% above the 52 week low of 2.02 set on Dec 09, 2022.
2.02Dec 09 202238.60Oct 03 2022
Short selling activityProvided by S&P Global Market Intelligence
|Market cap||74.35m USD|
|EPS (TTM)||-5.85 |
Data delayed at least 15 minutes, as of Mar 20 2023 11:26 BST.